Randomized, Placebo-Controlled Trial of Dobutamine for Low Superior Vena Cava Flow in Infants Marıa Carmen Bravo, MD, PhD1, Paloma Lopez-Ortego, MD1, Laura Sanchez, MD1, Joan Riera, MBE1,2, Rosario Madero, MD3, Fernando Caba~nas, MD, PhD1, and Adelina Pellicer, MD, PhD1 Objective To gather information for a future confirmatory trial of dobutamine (DB) for circulatory impairment (ie, low superior vena cava [SVC] flow).
Study design A total of 127 infants born at
Study design A total of 127 infants born at
